Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Vertex Resource Group Reports Record Fourth Quarter and Year End 2022 Results (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Medexus Pharmaceuticals Inc Ordinary Shares T.MDP

Alternate Symbol(s):  T.MDP.DB | MEDXF

Healthcare Drug Manufacturers - Major
Medexus Pharmaceuticals Inc, formerly Pediapharm Inc is a leading specialty pharmaceutical company with a strong North American commercial platform. It is focused on the therapeutic areas of auto-immune disease and pediatrics. The leading products are Rasuvo and Metoject, a unique formulation of methotrexate to treat rheumatoid arthritis and other auto-immune diseases; and Rupall, an innovative allergy medication with a unique mode of action.

The Power Play by The Market Herald
{{currentVideo.videoCaption}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous Video {{moreVideoText}} Next Video >

Stock Price Chart (TSX:MDP)

Fundamentals Snapshot (TSX:MDP)

Current News (TSX:MDP)

Medexus Announces New License Deal for Topical Terbinafine

GlobeNewswire 2 hours ago

Medexus Pharmaceuticals (TSX:MDP) announces US$58.5 million in new credit facilities

John Ballem  13 days ago

Medexus Announces US$58.5 million in New Credit Facilities

GlobeNewswire 13 days ago

Medexus to Participate in 35th Annual Roth Conference

GlobeNewswire March 6, 2023

Medexus Announces Another Record Quarter with Fiscal Q3 2023 Revenue of US$28.7 Million, a 35% Increase Over Fiscal Q3 2022

GlobeNewswire February 8, 2023

Medexus Welcomes Two New Board Members

GlobeNewswire February 6, 2023

Medexus Secures Public Reimbursement for Cuvposa® in Quebec

GlobeNewswire February 1, 2023

Medexus Schedules Third Fiscal Quarter 2023 Conference Call

GlobeNewswire January 31, 2023

Medexus Expects Record Revenue for Fiscal Q3 2023 and Provides Business Update

GlobeNewswire January 12, 2023
View More News ››

Opinion & Analysis (TSX:MDP)

VIDEO: Focused on Children's Medicine in an Underserved Market

BTV-Business Television June 8, 2016

Pediapharm (V.PDP) is a very attractive takeover candidate, Stockhouse poster says

Stockhouse Editorial April 20, 2015
View More Opinion ››

Bullboard Posts (TSX:MDP)

Back on and MDP

Any reason why Yahoo is showing the stock was halted on 23rd?
GoldenArm1 - February 28, 2023

RE:RE:RE:What's going on?

Apparently im not the only that noticed the flaws of this company that just been hammered by negative recommendations of brokers.
bingostar - February 15, 2023

Looks like medac is being help up by FDA

Since the FDA get 75% of its funding from Pharma, I think Treos would get approved if medac just cut them a cheque. It is approved in...
GoldenArm - January 13, 2023

RE:RE:What's going on?

Bingo ... U have to admit that sales r important else no cash flow is possible so they r constantly selling approx 25 mil $ every quarter...
Rockafellow2 - November 21, 2022

RE:What's going on?

Incorrect, you do not repay debt with sales only with cash flow and now they are cash flow breakeven. Their business model do not work ,...
bingostar - November 19, 2022

What's going on?

Isn't 100mil debt good if that is needed to make 200mil in product? If they weren't selling anything that debt would sink them...
Rockafellow2 - November 10, 2022
View more Bullboard ››

SWMBRD Sports Inc.

SWMBRD Sports Inc.

SWMBRD Sports Inc is a sporting goods company focused on developing, manufacturing, marketing, and selling aquatic sports ...
View More »